Skip to main content


Fig. 2 | Respiratory Research

Fig. 2

From: Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

Fig. 2

Forest plots for change from baseline in trough FEV1. (a) FF 100 μg versus placebo (ITT population), and (b) FF 200 μg versus placebo (ITT population). *In study NCT01499446, the final approved inhaler for FF delivery was not used [13]. Abbreviations: FEV 1 , forced expiratory volume in one second; FF, fluticasone furoate; ITT, intent-to-treat; LS, least squares; OD, once daily

Back to article page